Peri-Implantitis Market

Peri-Implantitis Market Size and Share:

The global peri-implantitis market size was valued at USD 1,153.95 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,241.39 Million by 2034, exhibiting a CAGR of 7.38% from 2026-2034. Europe currently dominates the market, holding a market share of 31% in 2025. The region benefits from advanced dental healthcare infrastructure, well-established reimbursement policies, a high prevalence of dental implant procedures, and proactive clinical research initiatives that collectively drive the demand for effective peri-implantitis treatment solutions, thereby contributing to the peri-implantitis market share.

The rising prevalence of dental implant procedures worldwide is a key factor fueling the demand for peri-implantitis treatment solutions. As the global geriatric population continues to expand, the need for tooth replacement therapies has increased substantially, resulting in a higher incidence of peri-implant diseases. The growing consumer awareness regarding oral hygiene and the availability of advanced diagnostic tools are further supporting early detection and treatment of peri-implantitis. Additionally, government initiatives across multiple nations promoting dental health, coupled with increasing investments in healthcare infrastructure, are creating favorable conditions for peri-implantitis market growth. Technological innovations in treatment approaches, including regenerative biomaterials, antimicrobial coatings, and laser-assisted debridement techniques, are transforming treatment outcomes and driving adoption. Furthermore, the expansion of dental insurance coverage and growing medical tourism for dental treatments are broadening patient access to advanced peri-implantitis care globally.

The United States has emerged as a major region in the peri-implantitis market owing to many factors. The country possesses a well-established healthcare infrastructure with a large network of dental professionals who are increasingly adopting innovative treatment modalities for peri-implant diseases. Rising incidences of periodontal conditions, combined with a growing aging population, are contributing to higher demand for dental implant procedures and subsequent peri-implantitis treatments. For instance, approximately three million dental implants are placed each year in the United States alone, and about 178 million Americans are missing at least one tooth as of 2025. The increasing awareness about oral health issues related to dental implants and the availability of advanced therapeutic options are propelling the demand for effective management solutions. Moreover, favorable reimbursement structures and significant healthcare spending are supporting the growth of the peri-implantitis treatment industry in the country.

To get more information on this market Request Sample

Peri-Implantitis Market Trends:

Rising Adoption of Surgical Interventions

The increasing adoption of surgical interventions for managing peri-implantitis is creating a positive outlook for the market. Surgical procedures, including open flap debridement, bone regeneration, and implantoplasty, have gained significant traction owing to their superior efficacy in addressing advanced cases of peri-implant bone loss. These procedures allow clinicians to achieve thorough decontamination of implant surfaces and facilitate the regeneration of lost bone tissue, which non-surgical methods alone often cannot accomplish effectively. The European Federation of Periodontology (EFP) S3 clinical guidelines recommend surgical approaches when non-surgical therapy fails to achieve adequate disease resolution. The growing body of clinical evidence validating surgical outcomes is encouraging more practitioners to adopt these techniques for comprehensive treatment protocols.

Advances in Implant Decontamination Technologies

The development of innovative implant surface decontamination technologies is emerging as a key trend shaping the peri-implantitis market outlook. Effective biofilm removal from contaminated implant surfaces remains a critical step in successful peri-implantitis therapy, and recent technological breakthroughs are offering improved solutions. Electrolytic cleaning systems, photodynamic therapy, and advanced air-polishing devices are being increasingly integrated into treatment workflows to enhance decontamination outcomes. These technologies enable thorough cleaning of complex implant surface geometries without damaging the underlying micro-structure, thereby supporting re-osseointegration and improved healing. The introduction of such novel decontamination devices is encouraging clinicians to adopt more predictable and standardized treatment protocols, resulting in better patient outcomes and expanding demand for advanced peri-implantitis care.

Growing Emphasis on Regenerative Biomaterials

The growing emphasis on regenerative biomaterials is playing a crucial role in advancing peri-implantitis treatment capabilities, contributing to the favorable peri-implantitis market forecast. Bone graft substitutes, collagen membranes, and growth factor-based products are increasingly being used in combination with surgical interventions to restore peri-implant bone defects and achieve long-term implant stability. Clinicians are utilizing guided bone regeneration techniques with advanced biomaterials to fill bone defects and promote tissue healing around compromised dental implants. Xenogeneic and allogenic bone substitutes have demonstrated significant radiographic bone level gains in clinical studies, making them preferred choices for reconstructive therapy. For instance, in November 2025, Geistlich Pharma AG announced plans to launch 20 new regenerative products in more than 40 countries by the end of 2026, including a flowable bone substitute containing 80% Bio-Oss and 20% Bio-Gide collagen for rapid application. The continuous innovation in biomaterial formulations is expanding treatment possibilities and improving clinical outcomes for patients with peri-implantitis.

Peri-Implantitis Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global peri-implantitis market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on method type and end user.

Analysis by Method Type:

To get detailed segment analysis of this market Request Sample

• Surgical
  • Bone Regeneration
  • Open Flap Debridement
  • Implantoplasty
• Non-Surgical
  • Mechanical Debridement
  • Laser Debridement
  • Antibiotics
  • Others

Surgical holds 60% of the market share. Surgical treatment approaches for peri-implantitis encompass a range of procedures, including bone regeneration, open flap debridement, and implantoplasty, which are designed to provide comprehensive management of advanced peri-implant bone loss. The surgical segment maintains its dominance owing to the superior efficacy of these procedures in achieving thorough decontamination of implant surfaces and enabling the regeneration of lost supporting bone structures. Clinicians increasingly favor surgical interventions because non-surgical methods alone have demonstrated limited success in resolving established peri-implantitis cases. The segment further benefits from continuous advancements in surgical techniques, including minimally invasive approaches and the integration of regenerative biomaterials that improve patient outcomes and reduce recovery times. The expanding evidence base supporting surgical efficacy continues to drive adoption across clinical settings worldwide.

Analysis by End User:

• Hospitals
• Dental Clinics
• Others

Hospitals lead the market with a share of 46%. Hospitals represent the dominant end-user segment in the peri-implantitis market, driven by their comprehensive infrastructure, availability of specialized surgical teams, and access to advanced diagnostic and treatment technologies. Hospitals offer the multidisciplinary skills that are necessary in the management of complex cases of peri-implantitis, such as oral surgeons, periodontists, and prosthodontists who collaborate to provide the best outcomes to patients. The segment can also be exploited by the growing government and institutional investment in infrastructure development of the healthcare sector, which is also increasing the capacity of performing advanced dental and surgical procedures. Moreover, hospitals also provide the controlled conditions that are required to conduct the so-called regenerative surgeries, including bone grafting and guided tissue regeneration, which demand the use of special equipment and post-operative monitoring facilities. The increasing number of multidisciplinary cases of dental diseases demanding multidisciplinary care is yet another statement that confirms the strategic role of hospitals as the primary market segment.

Regional Analysis:

To get more information on the regional analysis of this market Request Sample

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Europe, accounting for 31% of the share, enjoys the leading position in the market. The region maintains its dominance owing to the high prevalence of dental implant procedures, advanced healthcare infrastructure, and proactive clinical research initiatives focused on peri-implant disease management. Countries such as Germany, France, the United Kingdom, Italy, and Spain are key contributors to regional growth, benefiting from their advanced dental care infrastructure and high per capita healthcare expenditure. The region is witnessing steady adoption of advanced diagnostic and therapeutic solutions, supported by favorable government initiatives and growing collaboration between academic institutions and industry players. European clinical practice guidelines, including the European Federation of Periodontology S3 guidelines, provide standardized protocols for peri-implantitis management, promoting evidence-based treatment approaches. For instance, the prevalence of peri-implant disease reaches up to 43% among patient populations in Europe, as reported in a 2025 Frontiers in Microbiology study, highlighting the substantial clinical need driving the peri-implantitis market trends across the continent.

Key Regional Takeaways:

North America Peri-Implantitis Market Analysis

The North American peri-implantitis market is experiencing robust growth, driven by the region's advanced healthcare infrastructure, high rates of dental implant adoption, and increasing awareness about peri-implant disease management. The presence of a well-established network of dental professionals who are increasingly integrating innovative treatment modalities into their clinical practice is supporting the expansion of the market. The growing geriatric population in the region is contributing to higher demand for dental implant procedures and, consequently, for effective peri-implantitis management solutions. Rising healthcare expenditure, favorable reimbursement structures, and the availability of cutting-edge surgical technologies are further reinforcing growth prospects. Additionally, leading dental companies are investing significantly in research and development activities to introduce advanced biomaterials and decontamination systems specifically designed for peri-implantitis therapy. For instance, according to the Population Reference Bureau, the number of individuals aged 65 and older in the United States is projected to increase from 58 million in 2022 to 82 million by 2050, substantially expanding the patient pool requiring dental implant procedures and associated treatments. The strong focus on patient education and preventive oral healthcare programs is also contributing to earlier detection and treatment of peri-implant conditions across the region.

United States Peri-Implantitis Market Analysis

The United States peri-implantitis market is witnessing significant growth, supported by the country's robust healthcare system, advanced dental care facilities, and a large population of dental implant recipients. The increasing prevalence of periodontal conditions, coupled with the expanding aging demographic, is driving higher demand for dental implant procedures and subsequent peri-implantitis treatments. The country benefits from a highly skilled dental workforce that is actively adopting innovative treatment modalities, including electrolytic cleaning systems, regenerative biomaterials, and laser-assisted debridement techniques, to manage peri-implant diseases effectively. The rising consumer awareness about the importance of oral health maintenance and regular dental check-ups is supporting earlier detection of peri-implantitis, enabling timely intervention and improved clinical outcomes. Furthermore, significant investments in dental research and the presence of leading industry players are accelerating the introduction of novel therapeutic solutions. For instance, approximately 93% of dental implant cases in the United States utilize titanium-based implants as of 2025, reflecting the widespread adoption of implant dentistry and the corresponding need for effective peri-implantitis management protocols. The growing penetration of dental insurance coverage and increasing healthcare spending continue to strengthen the market landscape in the country.

Europe Peri-Implantitis Market Analysis

The European peri-implantitis market is characterized by a high prevalence of dental implant procedures, strong regulatory frameworks, and active participation in clinical research. Germany, France, the United Kingdom, Italy, and Spain are some of the leading contributors to the growth of the region, and these countries have the advantage of well-developed dental care structures and substantial healthcare spending. The adoption of advanced diagnostic and therapeutic solutions in the region is also on a steady rise due to the positive government initiative and increased cooperation between the academic and industry players. Guidelines in clinical practice in Europe, such as the European Federation of Periodontology S3 guidelines, offer standard procedures of management of peri-implantitis, which are likely to advance evidence-based treatment models. For instance, in July 2025, the European Federation of Periodontology (EFP) launched three infographics to help dental professionals apply its S3-level guidelines on preventing and managing peri-implant diseases. These visuals highlight key evidence-based recommendations and provide practical guidance to support peri-implant health and long-term implant success. The increasing geriatric population, growing awareness about dental health, and promising reimbursement policies across European nations are driving the demand for comprehensive peri-implantitis treatment solutions in the region.

Asia-Pacific Peri-Implantitis Market Analysis

The Asia-Pacific peri-implantitis market is poised for rapid growth, driven by improving access to dental care, increasing awareness about oral health, and a rising prevalence of dental implant procedures across the region. Countries such as China, Japan, India, South Korea, and Australia are witnessing expanding investments in dental healthcare infrastructure and growing adoption of advanced treatment technologies. The region's large and rapidly aging population is creating a substantial patient pool requiring dental implant procedures and subsequent management of peri-implant complications. For instance, according to a 2024 Global Burden of Disease analysis published in The Lancet, oral disorders affected approximately 3.69 billion people globally in 2021, with Southeast Asia recording among the highest age-standardized incidence rates. The growing dental tourism industry, expanding health insurance coverage, and increasing disposable incomes are further facilitating access to advanced peri-implantitis treatment solutions across Asia-Pacific markets.

Latin America Peri-Implantitis Market Analysis

The Latin American peri-implantitis market is experiencing steady growth, supported by increasing awareness about oral health, expanding dental care infrastructure, and growing adoption of dental implant procedures. Brazil and Mexico represent the leading markets in the region, benefiting from improving healthcare access and rising disposable incomes. The region is witnessing increased investments from global dental companies seeking to expand their presence in emerging markets. For instance, in April 2024, Geistlich Pharma AG acquired Bionnovation Biomedical in Brazil to expand its regenerative product portfolio and provide affordable dental treatment solutions in Latin America. The growing emphasis on preventive dental care and improving reimbursement structures are expected to further accelerate market growth across the region.

Middle East and Africa Peri-Implantitis Market Analysis

The Middle East and Africa peri-implantitis market is gradually expanding, driven by increasing healthcare investments, growing urbanization, and rising awareness about dental health. The region is witnessing improvements in dental care infrastructure, with several countries investing in modernizing healthcare facilities and training dental professionals in advanced treatment techniques. The growing medical tourism industry, particularly in countries such as the United Arab Emirates and Saudi Arabia, is attracting international patients seeking advanced dental treatments. For instance, in March 2025, the WHO published updated oral health data confirming that oral diseases affect nearly 3.7 billion people globally, underscoring the urgent need for expanded dental care access in developing regions. Rising government focus on oral health programs and increasing public-private partnerships are supporting the gradual expansion of peri-implantitis treatment services across the region.

Competitive Landscape:

The global peri-implantitis market features a moderately competitive landscape characterized by the presence of key players focusing on product innovation, strategic acquisitions, and expanding their global distribution networks. Leading companies are investing in next-generation biomaterials, regenerative therapies, and advanced implant decontamination technologies to strengthen their market positions. Strategic collaborations between academic institutions and industry players are driving the development of standardized treatment protocols and innovative therapeutic solutions. Major players are also pursuing geographic expansion through acquisitions and partnerships to enhance their presence in emerging markets. The competitive environment is further shaped by continuous research and development activities aimed at improving treatment efficacy and patient outcomes. Companies are increasingly adopting digital innovations, including computer-aided design and three-dimensional printing technologies, to create customized regenerative solutions that address individual patient requirements. Regulatory approvals and clinical evidence generation remain critical differentiators for market participants.

The report provides a comprehensive analysis of the competitive landscape in the peri-implantitis market with detailed profiles of all major companies, including:

• botiss biomaterials GmbH
• Geistlich Pharma AG
• Silveraid S.r.l.
• Straumann Holding AG

Latest News and Developments:

• In August 2025, Straumann Group reported revenue of CHF 1.3 billion for the first half of 2025, achieving +10.2% organic revenue growth. The company continued to expand its regenerative solutions portfolio, including GalvoSurge electrolytic implant cleaning technology for peri-implantitis treatment. Straumann also acquired full ownership of maxon dental GmbH, gaining advanced ceramic implant manufacturing capabilities through proprietary ceramic injection molding technology.
   
• In February 2025, Geistlich Pharma AG announced a strategic investment in ReOss Ltd., a company specializing in patient-specific digital solutions that combine digital patient data with three-dimensional printing technology. This equity stake demonstrates Geistlich's commitment to strengthening its portfolio with customized regenerative solutions and advancing computer-aided processes to reduce treatment times and improve patient care in dental regeneration procedures.

Peri-Implantitis Market Report Scope:

Key Benefits for Stakeholders:

• IMARC's report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the peri-implantitis market from 2020-2034.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global peri-implantitis market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Peri-Implantitis industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.